Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLCB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GRIK1-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HPYR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PRKCE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STKLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INPP5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP26B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPG2IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130938 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRODH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIRREL3-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYCNOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on